Hepatitis A and B combination Vaccine for adults and children/adolescents 2025-2027 (2027-2028, 2028-2029)

The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Hepatitis A and B combination Vaccine belonging to the National Vaccination Programme in Finland. The contract will be awarded to one Supplier based on a …

CPV: 33651600 Vaccines, 33600000 Pharmaceutical products, 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
áit fhorghníomhaithe:
Hepatitis A and B combination Vaccine for adults and children/adolescents 2025-2027 (2027-2028, 2028-2029)
clárlann:
Ministry of Social Affairs and Health
uimhir dámhachtana:
THL/6198/2.02.06/2024

1. Buyer

1.1 Buyer

Official name : Ministry of Social Affairs and Health
Legal type of the buyer : Body governed by public law, controlled by a central government authority
Activity of the contracting authority : Health

2. Procedure

2.1 Procedure

Title : Hepatitis A and B combination Vaccine for adults and children/adolescents 2025-2027 (2027-2028, 2028-2029)
Description : The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Hepatitis A and B combination Vaccine belonging to the National Vaccination Programme in Finland. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The most economically advantageous Tender shall be a Tender with lowest reference price for the competition. The reference price will be calculated by adding the tendered prices for adult and children/adolescent doses together. The tenderer must offer a price for both adult and children´s vaccines. The contract period is two years 2025 - 2027. The procurement contains two one-year contract period renewals (1+1) to extend the contract for the periods 2027-2028 and 2028-2029. Estimated quantity for the contract period including contract period renewals is 12 000 doses for adults and 1000 doses for children/adolescents. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. Please note that all times given in the Call for Tender refer to local time in Finland. Call for Tenders, annexes: Annex 1 Contract Annex 2 JYSE 2014 SUPPLIES (updated version of April 2022) Annex 3 Delivery schedule Annex 4 Subcontractors Annex 5 Description of the Handi Service
Procedure identifier : 0e18a9b8-cbb3-4b12-a318-e13afeeeed7a
Previous notice : 81404491-3581-44a2-a7a2-9cdab5b93ba7-01
Internal identifier : THL/6198/2.02.06/2024
Type of procedure : Open
The procedure is accelerated : no
Main features of the procedure : An open procedure is applied. The procurement will take place in compliance with the Directive 2014/24/EU on public procurement and the Finnish Act on Public Procurement and Concession Contracts (1397/2016). The estimated value of the procurement will exceed the EU threshold value. In case none of the tenders received meets the requirements of the Call for Tender as intended by the Customer, or if conditions change during the procurement process so that the Customer will be unable to make use of the results of the competitive bidding, the Customer may interrupt the procurement procedure. No compensation will be paid to the tenderers for preparing a tender, presenting it or other participations in the procedure. The Call for Tender documents are available in English.

2.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 33651600 Vaccines
Additional classification ( cpv ): 33600000 Pharmaceutical products
Additional classification ( cpv ): 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents

2.1.2 Place of performance

Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland

2.1.4 General information

Additional information : The purpose of STM and the Customer is to procure Hepatitis A and B combination Vaccine required for the National Vaccination Programme in Finland. The tendered vaccines must be suitable for adults and children/adolescents according to Article´s Summary of Product Characteristics (SPC). The Customer should prefer syringes without fixed needles. This procurement is not divided into lots. According to Communicable Diseases Act (1227/2016) the Finnish Institute for Health and Welfare has an obligation to supervise the implementation of the national immunization programme and other general vaccinations and monitor the implementation and impact of the vaccinations. Dividing the procurement into lots could cause a risk for medication deviation if products with different dosages (different amount of doses in vaccination course or different concentrations) would be in use for adult and pediatric population. More information about National Vaccination Programme and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/hepatiittirokotteet/hepatiitti-a-ja-b-rokote The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority". The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders. If the Supplier has modified vaccine available/ releases a modified vaccine during the contract period, the Parties may agree to substitute the Article with the modified vaccine. In case of substitution, all terms and prices in the Contract shall apply without modification. CONTRACT PERIOD The Contract shall enter into a force once the competent signatories of the Contracting Parties have duly signed the Contract. The Contract shall expire when all contractual duties and obligations have been performed by both Parties. However, the contract period shall be counted from the first day of the month on which the Supplier has handed over the first delivery lot of the Articles to a Customer’s pharmaceutical wholesaler. The Contract period is two (2) years from the date defined previously above and the estimated quantity to be purchased for this period is 6000 doses (+/- 20%) for adults and 500 doses (+/- 20%) for children/adolescents. After the contract period, the Customer reserves the right for the contract period renewals described in section "Description of renewals". Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tenders.
Legal basis :
Directive 2014/24/EU

5. Lot

5.1 Lot technical ID : LOT-0000

Title : Hepatitis A and B combination Vaccine for adults and children/adolescents 2025-2027 (2027-2028, 2028-2029)
Description : The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Hepatitis A and B combination Vaccine belonging to the National Vaccination Programme in Finland. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The most economically advantageous Tender shall be a Tender with lowest reference price for the competition. The reference price will be calculated by adding the tendered prices for adult and children/adolescent doses together. The tenderer must offer a price for both adult and children´s vaccines. The contract period is two years 2025 - 2027. The procurement contains two one-year contract period renewals (1+1) to extend the contract for the periods 2027-2028 and 2028-2029. Estimated quantity for the contract period including contract period renewals is 12 000 doses for adults and 1000 doses for children/adolescents. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. Please note that all times given in the Call for Tender refer to local time in Finland. Call for Tenders, annexes: Annex 1 Contract Annex 2 JYSE 2014 SUPPLIES (updated version of April 2022) Annex 3 Delivery schedule Annex 4 Subcontractors Annex 5 Description of the Handi Service
Internal identifier : THL/6198/2.02.06/2024

5.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 33651600 Vaccines
Additional classification ( cpv ): 33600000 Pharmaceutical products
Additional classification ( cpv ): 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents

5.1.2 Place of performance

Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Additional information :

5.1.3 Estimated duration

Duration : 24 Month

5.1.4 Renewal

Maximum renewals : 2
Other information about renewals : The procurement contains two one-year contract period renewals (1+1) to extend the contract. Estimated quantity for one contract period renewal is 3000 doses (+/-20 %) for adults and 250 doses (+/- 20 %) for children/adolescents. The customer can extend the contract period with one or two Contract period renewals at a time.

5.1.6 General information

Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA) : yes
Additional information : The purpose of STM and the Customer is to procure Hepatitis A and B combination Vaccine required for the National Vaccination Programme in Finland. The tendered vaccines must be suitable for adults and children/adolescents according to Article´s Summary of Product Characteristics (SPC). The Customer should prefer syringes without fixed needles. This procurement is not divided into lots. According to Communicable Diseases Act (1227/2016) the Finnish Institute for Health and Welfare has an obligation to supervise the implementation of the national immunization programme and other general vaccinations and monitor the implementation and impact of the vaccinations. Dividing the procurement into lots could cause a risk for medication deviation if products with different dosages (different amount of doses in vaccination course or different concentrations) would be in use for adult and pediatric population. More information about National Vaccination Programme and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/hepatiittirokotteet/hepatiitti-a-ja-b-rokote The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority". The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders. If the Supplier has modified vaccine available/ releases a modified vaccine during the contract period, the Parties may agree to substitute the Article with the modified vaccine. In case of substitution, all terms and prices in the Contract shall apply without modification. CONTRACT PERIOD The Contract shall enter into a force once the competent signatories of the Contracting Parties have duly signed the Contract. The Contract shall expire when all contractual duties and obligations have been performed by both Parties. However, the contract period shall be counted from the first day of the month on which the Supplier has handed over the first delivery lot of the Articles to a Customer’s pharmaceutical wholesaler. The Contract period is two (2) years from the date defined previously above and the estimated quantity to be purchased for this period is 6000 doses (+/- 20%) for adults and 500 doses (+/- 20%) for children/adolescents. After the contract period, the Customer reserves the right for the contract period renewals described in section "Description of renewals". Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tenders.

5.1.7 Strategic procurement

Innovative objective : The procured works, supplies or services are novel or significantly improved compared to other works, supplies, or services already on the market.

5.1.10 Award criteria

Criterion :
Type : Price
Description : The reference price for the tender will be counted with the following formula (price per dose for the adult vaccine * 6000 doses) + (price per dose for the pediatric vaccine x 500 doses)=Reference price.
Category of award weight criterion : Fixed value (total)
Award criterion number : 100

5.1.15 Techniques

Framework agreement :
No framework agreement
Information about the dynamic purchasing system :
No dynamic purchase system

5.1.16 Further information, mediation and review

Review organisation : Markkinaoikeus
Information about review deadlines : In a procurement exceeding the EU threshold value, the contract may be concluded no earlier than 14 days after the tenderer has received or is deemed to have received the decision and the appeal notice (waiting period).

6. Results

Value of all contracts awarded in this notice : 798 288 Euro

6.1 Result lot ldentifier : LOT-0000

At least one winner was chosen.

6.1.2 Information about winners

Winner :
Official name : GlaxoSmithKline Oy
Tender :
Tender identifier : tenderReference-4242538-839949
Identifier of lot or group of lots : LOT-0000
Value of the tender : 798 228 Euro
Subcontracting : No
Contract information :
Identifier of the contract : THL/6198/2.02.06/2024
Date on which the winner was chosen : 23/05/2025
Date of the conclusion of the contract : 20/08/2025

6.1.4 Statistical information

Received tenders or requests to participate :
Type of received submissions : Tenders submitted electronically
Number of tenders or requests to participate received : 1

8. Organisations

8.1 ORG-0001

Official name : Markkinaoikeus
Registration number : 3006157-6
Postal address : Radanrakentajantie 5
Town : Helsinki
Postcode : 00520
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Telephone : +358 295643300
Roles of this organisation :
Review organisation

8.1 ORG-0002

Official name : Ministry of Social Affairs and Health
Registration number : 0244685-8
Postal address : P.O. BOX 33
Town : Helsinki
Postcode : 00023
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Contact point : Hankintayksikkö
Telephone : +358 295246000
Roles of this organisation :
Buyer

8.1 ORG-0003

Official name : GlaxoSmithKline Oy
Size of the economic operator : Large
Registration number : 0108378-4
Postal address : Porkkalankatu 20 A
Town : Helsinki
Postcode : 00180
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Roles of this organisation :
Tenderer
Winner of these lots : LOT-0000

8.1 ORG-0004

Official name : Hansel Oy (Hilma)
Registration number : FI09880841
Postal address : Mannerheiminaukio 1a
Town : Helsinki
Postcode : 00100
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Contact point : eSender
Telephone : 029 55 636 30
Roles of this organisation :
TED eSender

Notice information

Notice identifier/version : b51b0901-2713-47a3-a53e-0125ce8a449b - 01
Form type : Result
Notice type : Contract or concession award notice – standard regime
Notice dispatch date : 17/09/2025 06:26 +00:00
Notice dispatch date (eSender) : 17/09/2025 06:27 +00:00
Languages in which this notice is officially available : English
Notice publication number : 00611497-2025
OJ S issue number : 179/2025
Publication date : 18/09/2025